CRISPR: The Gene Editing Revolution | Golden Age

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is a gene editing tool that has taken the scientific community by storm since its discovery in 2012 by Jennifer Doudna and Emmanuelle Charpentier. With a vibe rating of 8, CRISPR has the potential to revolutionize the treatment of genetic diseases, but it also raises concerns about ethics and unintended consequences. The technology works by using a small RNA molecule to locate a specific sequence of DNA and then cutting it, allowing for precise editing of the genome. However, the use of CRISPR has been marred by controversy, including a heated patent dispute between the Broad Institute and the University of California, Berkeley. As of 2022, CRISPR has been used in various applications, including cancer treatment and regenerative medicine, with over 1,000 clinical trials underway worldwide. Despite the promise, the long-term effects of CRISPR are still unknown, and the scientific community is eagerly awaiting the results of ongoing research to fully understand its potential and limitations.